BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 2012; 18(1): 1-15 [PMID: 22228965 DOI: 10.3748/wjg.v18.i1.1]
URL: https://www.wjgnet.com/1007-9327/full/v18/i1/1.htm
(0) (0) (18547) (141)
Number Citing Articles
1
Andrea A. Gossard, Gregory J. Gores. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2017; 21(4) doi: 10.1016/j.cld.2017.06.004
2
Andres F. Carrion, Kalyan Ram Bhamidimarri. Liver Transplant for Cholestatic Liver Diseases. Clinics in Liver Disease 2013; 17(2) doi: 10.1016/j.cld.2012.12.005
3
Yujie Zhang, Xinbao Gao, Zhiyi He, Hui Jia, Min Chen, Xuan Wang, Liu Hong, Yuanyuan Cui, Jian Wan. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta‐analysis. Liver International 2022; 42(8) doi: 10.1111/liv.15339
4
T. H. Karlsen, M. Vesterhus, K. M. Boberg. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2014; 39(3) doi: 10.1111/apt.12581
5
Won Kim. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases. 2022;  doi: 10.1007/978-981-19-0120-1_14
6
Siddharth Singh, Jayant A. Talwalkar. Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management. Clinical Gastroenterology and Hepatology 2013; 11(8) doi: 10.1016/j.cgh.2013.02.016
7
Lina Lindström, Kristin K. Jørgensen, Kirsten M. Boberg, Maria Castedal, Allan Rasmussen, Andreas Arendtsen Rostved, Helena Isoniemi, Matteo Bottai, Annika Bergquist. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study. Scandinavian Journal of Gastroenterology 2018; 53(3) doi: 10.1080/00365521.2017.1421705
8
Francesco Paolo Russo, Alberto Zanetto. Textbook of Liver Transplantation. 2022;  doi: 10.1007/978-3-030-82930-8_22
9
Fanni Gelley, Gergely Zádori, Dénes Görög, László Kóbori, Imre Fehérvári, György Gámán, Zsuzsanna Gerlei, Péter Nagy, Enikő Sárváry, Balázs Nemes. Recurrence of primary sclerosing cholangitis after liver transplantation — The Hungarian experience. Interventional Medicine and Applied Science 2014; 6(1) doi: 10.1556/imas.6.2014.1.2
10
Yang Shi, Shuqun Hu, Qingwei Song, Shengcai Yu, Xiaojun Zhou, Jun Yin, Lei Qin, Haixin Qian. Gene Silencing of 4-1BB by RNA Interference Inhibits Acute Rejection in Rats with Liver Transplantation. BioMed Research International 2013; 2013 doi: 10.1155/2013/192738
11
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti. Main factors influencing long-term outcomes of liver transplantation in 2022. World Journal of Hepatology 2023; 15(3): 321-352 doi: 10.4254/wjh.v15.i3.321
12
Peder Rustøen Braadland, Annika Bergquist, Martin Kummen, Lars Bossen, Lise Katrine Engesæter, Henrik Mikael Reims, Ida Björk, Krzysztof Grzyb, Andreas Abildgaard, Milada Cvancarova Småstuen, Trine Folseraas, Marius Trøseid, Arve Ulvik, Per Magne Ueland, Espen Melum, Pål-Dag Line, Marte Lie Høivik, Henning Grønbæk, Tom Hemming Karlsen, Mette Vesterhus, Johannes Roksund Hov. Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation. Journal of Hepatology 2023; 79(4) doi: 10.1016/j.jhep.2023.05.038
13
Itaru Naitoh, Hiroyuki Isayama, Nobuhisa Akamatsu, Suguru Mizuno, Toshio Fujisawa, Nobuhiro Nakamoto, Yousuke Nakai, Shuichiro Umetsu, Mitsuyoshi Suzuki, Shintaro Yagi, Hironori Haga, Kenji Notohara, Katsuhiro Sano, Susumu Tazuma, Takahiro Nakazawa, Atsushi Tanaka. The 2024 diagnostic criteria for primary sclerosing cholangitis. Journal of Gastroenterology 2025; 60(10) doi: 10.1007/s00535-025-02265-5
14
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016;  doi: 10.1007/978-3-319-05543-5_21-2
15
A. J. Montano-Loza, R. A. Bhanji, S. Wasilenko, A. L. Mason. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Alimentary Pharmacology & Therapeutics 2017; 45(4) doi: 10.1111/apt.13894
16
Michael P. Manns, Annika Bergquist, Tom H. Karlsen, Cynthia Levy, Andrew J. Muir, Cyriel Ponsioen, Michael Trauner, Grace Wong, Zobair M. Younossi. Primary sclerosing cholangitis. Nature Reviews Disease Primers 2025; 11(1) doi: 10.1038/s41572-025-00600-x
17
Christina W. Lee, Sean Ronnekleiv-Kelly. Autoimmune Diseases of the Biliary Tract. Surgical Clinics of North America 2019; 99(2) doi: 10.1016/j.suc.2018.11.003
18
Claire Durkin, Therese Bittermann. Liver transplantation for alcohol-associated hepatitis. Current Opinion in Organ Transplantation 2023; 28(2) doi: 10.1097/MOT.0000000000001044
19
EASL Clinical Practice Guidelines: Liver transplantation. Journal of Hepatology 2016; 64(2) doi: 10.1016/j.jhep.2015.10.006
20
Nora V. Bergasa. Clinical Cases in Hepatology. 2022;  doi: 10.1007/978-1-4471-4715-2_5
21
Ivo W. Graziadei. Recurrence of Nonviral Liver Diseases After Liver Transplantation. Clinics in Liver Disease 2014; 18(3) doi: 10.1016/j.cld.2014.05.009
22
Sridhar Sundaram, Vaneet Jearth. Primary Sclerosing Cholangitis: A Clinical Update. European Medical Journal 2019;  doi: 10.33590/emj/10313809
23
Mikio Zeniya, Masaki Iwai, Arief A. Suriawinata. Diagnosis of Liver Disease. 2019;  doi: 10.1007/978-981-13-6806-6_9
24
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantation. Portal Hypertension & Cirrhosis 2024; 3(1) doi: 10.1002/poh2.70
25
Denise M. Harnois, Kymberly D. S. Watt. Cholestatic Liver Disease. Clinical Gastroenterology 2014;  doi: 10.1007/978-1-4939-1013-7_10
26
Johannes Klose, Michelle A. Klose, Courtney Metz, Frank Lehner, Michael P. Manns, Juergen Klempnauer, Nils Hoppe, Harald Schrem, Alexander Kaltenborn. Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbeck's Archives of Surgery 2014; 399(8) doi: 10.1007/s00423-014-1214-6
27
Ken Liu, Simone I. Strasser, David J. Koorey, Rupert W. Leong, Michael Solomon, Geoffrey W. McCaughan. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Review of Gastroenterology & Hepatology 2017; 11(10) doi: 10.1080/17474124.2017.1343666
28
Marianna Maspero, Stefan D. Holubar, Roma Raj, Sumeyye Yilmaz, Christopher Prien, Olga Lavryk, Alejandro Pita, Koji Hashimoto, Scott R. Steele, Tracy L. Hull. Ileal Pouch-anal Anastomosis in Primary Sclerosing Cholangitis-inflammatory Bowel Disease (PSC-IBD). Annals of Surgery 2023; 278(6) doi: 10.1097/SLA.0000000000006041
29
Aditi Kumar, Daniel Wheatley, Amar Puttanna. Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management. Clinical Medicine Insights: Gastroenterology 2016; 9 doi: 10.4137/CGast.S38451
30
Ertan Emek, Ayfer Serin, Tolga Sahin, Pinar Yazici, Yildiray Yuzer, Yaman Tokat, Birkan Bozkurt. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience. Transplantation Proceedings 2019; 51(7) doi: 10.1016/j.transproceed.2019.01.156
31
Hannah R. Hrncir, Fransky Hantelys, Adam D. Gracz. Panic at the Bile Duct. The American Journal of Pathology 2023; 193(10) doi: 10.1016/j.ajpath.2023.02.012
32
Yash R Shah, Natalia Nombera-Aznaran, David Guevara-Lazo, Ernesto Calderon-Martinez, Angad Tiwari, SriLakshmiDevi Kanumilli, Purva Shah, Bhanu Siva Mohan Pinnam, Hassam Ali, Dushyant Singh Dahiya. Liver transplant in primary sclerosing cholangitis: Current trends and future directions. World Journal of Hepatology 2023; 15(8): 939-953 doi: 10.4254/wjh.v15.i8.939
33
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2017;  doi: 10.1007/978-3-319-07209-8_21
34
David Uihwan Lee, Samantha Menegas, Ki Jung Lee, Alex Pu, Kuntal Bhowmick, Reid Ponder, Gregory Hongyuan Fan, Harrison Chou, KeeSeok Lee, Nathalie H. Urrunaga. Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences 2023; 68(9) doi: 10.1007/s10620-023-08023-y
35
Rachita Khot, Matthew A. Morgan, Rashmi T. Nair, Daniel R. Ludwig, Hina Arif-Tiwari, Chandra S. Bhati, Malak Itani. Radiologic findings of biliary complications post liver transplantation. Abdominal Radiology 2022; 48(1) doi: 10.1007/s00261-022-03714-y
36
Nathalie A. Pena Polanco, Cynthia Levy, Eric F. Martin. Cholestatic Liver Diseases After Liver Transplant. Clinics in Liver Disease 2017; 21(2) doi: 10.1016/j.cld.2016.12.011
37
Sinan Efe Yazıcı, Ahmet Atasever, Şencan Acar, Yıldıray Yuzer. Liver Transplantation for Primary Sclerosing Cholangitis: A 20-Year Single-Center Experience. Hitit Medical Journal 2026; 8(2) doi: 10.52827/hititmedj.1884545
38
Michael R. Lucey, Norah Terrault, Lolu Ojo, Eileen J. Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transplantation 2013; 19(1) doi: 10.1002/lt.23566
39
Olalekan Lee Aiyegbusi, Fatima Isa, Derek Kyte, Tanya Pankhurst, Larissa Kerecuk, James Ferguson, Graham Lipkin, Melanie Calvert. Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study. Health and Quality of Life Outcomes 2020; 18(1) doi: 10.1186/s12955-020-01438-5
40
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77(2) doi: 10.1002/hep.32771
41
Kate D. Williamson, Roger W. Chapman. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin 2015; 114(1) doi: 10.1093/bmb/ldv019
42
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases. 2014;  doi: 10.1016/B978-0-12-384929-8.00063-0
43
Bijan Eghtesad, John J. Fung. Pouchitis and Ileal Pouch Disorders. 2019;  doi: 10.1016/B978-0-12-809402-0.00039-3
44
Delal Akdag, Andreas Arendtsen Rostved, Allan Rasmussen, Gro Linno Willemoe, Deepthi Chiranth, Bo‐Göran Ericzon, Carl Jorns, William Bennet, Arno Nordin, Fredrik Åberg, Jens Georg Hillingsø, Susanne Dam Nielsen, Hans‐Christian Pommergaard. Fibrosis in One‐Year Protocol Biopsies After Liver Transplantation Is Associated With Graft Loss: A Multicenter Cohort Study. APMIS 2026; 134(8) doi: 10.1111/apm.70250
45
Christina Villard, Ingalill Friis-Liby, Fredrik Rorsman, Karouk Said, Anna Warnqvist, Martin Cornillet, Stergios Kechagias, Nils Nyhlin, Mårten Werner, Izabella Janczewska, Therese Hagström, Emma Nilsson, Annika Bergquist. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. Journal of Hepatology 2023; 78(3) doi: 10.1016/j.jhep.2022.11.011
46
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016;  doi: 10.1007/978-3-319-05543-5_21-1
47
Mary Ayers, Silvia Liu, Aatur D. Singhi, Karis Kosar, Pamela Cornuet, Kari Nejak-Bowen. Changes in beta-catenin expression and activation during progression of primary sclerosing cholangitis predict disease recurrence. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-021-04358-6
48
Wenyi Chen, Jiaqi Zhu, Feiyan Lin, Yanping Xu, Bing Feng, Xudong Feng, Xinyu Sheng, Xiaowei Shi, Qiaoling Pan, Jinfeng Yang, Jiong Yu, Lanjuan Li, Hongcui Cao. Human placenta mesenchymal stem cell-derived exosomes delay H2O2-induced aging in mouse cholangioids. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02271-3
49
Frank Schmitz. MR-Cholangiographie bringt Licht ins Dunkel der PSC bei chronisch-entzündlicher Darmerkrankung. Der Gastroenterologe 2016; 11(6) doi: 10.1007/s11377-016-0119-z
50
Gupse Adali, Sencan Acar, Murat Harputluoğlu, Tonguç Utku Yılmaz, Hamdi Karakayalı, Zülal Istemihan, Sabahattin Kaymakoğlu, Çiğdem Arıkan, Murat Akyıldız, Nilay Daniş, Mehmet Akça, Mesut Akarsu, Dilara Turan Gökçe, Derya Arı, Meral Akdoğan Kayhan, Haydar Adanır, Dinç Dinçer, Elvan Işık, İlker Turan, Fulya Günşar, Volkan Yılmaz, Hale Gökcan, Zeki Karasu, Ramazan Idilman. Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis. Clinical Transplantation 2026; 40(1) doi: 10.1111/ctr.70436
51
Siddharth Singh, Edward V Loftus, Jayant A Talwalkar. Inflammatory Bowel Disease after Liver Transplantation for Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2013; 108(9) doi: 10.1038/ajg.2013.163
52
Chelsea E. Powell, Megan D. McCurry, Silvia Fernanda Quevedo, Lindsay Ventura, Kumar Krishnan, Malav Dave, Shaikh Danish Mahmood, Katherine Specht, Raghav Bordia, Molly R. Sargen, Daniel S. Pratt, Joshua R. Korzenik, A. Sloan Devlin, Vincent B. Young. Cultured bacteria isolated from primary sclerosing cholangitis patient bile induce inflammation and cell death. mSphere 2025; 10(11) doi: 10.1128/msphere.00550-25
53
Chaoran Zhang, Trana Hussaini, Eric M Yoshida. Review of pharmacotherapeutic treatments for primary sclerosing cholangitis. Canadian Liver Journal 2019; 2(3) doi: 10.3138/canlivj-2018-0016
54
Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo, Sergio Iván Hoyos-Duque. Colangitis esclerosante primaria. Una revisión narrativa. Iatreia 2020; 33(3) doi: 10.17533/udea.iatreia.57
55
Lydia M. Petrovic. Recurrent diseases following liver transplantation. Current Opinion in Organ Transplantation 2012; 17(3) doi: 10.1097/MOT.0b013e32835365f6
56
Christopher L. Welle, Patrick J. Navin, Michael C. Olson, Safa Hoodeshenas, Michael S. Torbenson, Sudhakar K. Venkatesh. MR elastography in primary sclerosing cholangitis: a pictorial review. Abdominal Radiology 2022; 48(1) doi: 10.1007/s00261-022-03529-x
57
Veena L Venkat, Sarangarajan Ranganathan, Rakesh Sindhi. The challenges of liver transplantation in children with primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 2015; 9(3) doi: 10.1586/17474124.2015.1002085
58
Mohamad A. Mouchli, Mohamed K. Osman, Bradley Busebee, Timucin Taner, Julie K. Heimbach, John Eaton, Omar Mousa, Kristin Cole, Kymberly D. Watt. Long-term (15 y) complications and outcomes after liver transplantation for primary sclerosing cholangitis: Impact of donor and recipient factors. Liver Transplantation 2025; 31(6) doi: 10.1097/LVT.0000000000000523
59
Palak J. Trivedi, Irene Scalera, Emma Slaney, Richard W. Laing, Bridget Gunson, Gideon M. Hirschfield, Andrea Schlegel, James Ferguson, Paolo Muiesan. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis. Journal of Hepatology 2017; 67(5) doi: 10.1016/j.jhep.2017.06.027
60
Varun Saxena, Norah A. Terrault. Zakim and Boyer's Hepatology. 2018;  doi: 10.1016/B978-0-323-37591-7.00053-7
61
Trygve Thorsen, Einar Martin Aandahl, William Bennet, Michael Olausson, Bo-Göran Ericzon, Greg Nowak, Frans Duraj, Helena Isoniemi, Allan Rasmussen, Tom H. Karlsen, Aksel Foss. Transplantation With Livers From Deceased Donors Older Than 75 Years. Transplantation 2015; 99(12) doi: 10.1097/TP.0000000000000728
62
Jonathan Merola, Robert M. Mocharla, Alexander Z. Jow, Samuel H. Sigal, Amar Safdar. Principles and Practice of Transplant Infectious Diseases. 2019;  doi: 10.1007/978-1-4939-9034-4_17
63
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4) doi: 10.1097/HEP.0000000000000506
64
Harald Hofer, Emina Halilbasic, Katharina Staufer, Michael Trauner. Liver Immunology. 2014;  doi: 10.1007/978-3-319-02096-9_20
65
Sanjaya K. Satapathy, Ollie D. Jones, Jason M. Vanatta, Faisal Kamal, Satish K. Kedia, Yu Jiang, Satheesh P. Nair, James D. Eason. Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid. Transplantation Direct 2017; 3(7) doi: 10.1097/TXD.0000000000000693
66
Brian K. Chung, Tom Hemming Karlsen, Trine Folseraas. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4) doi: 10.1016/j.bbadis.2017.08.020
67
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023;  doi: 10.1007/978-3-031-14744-9_11
68
Michael R. Lucey. Liver Transplantation. 2013;  doi: 10.1002/9781118675915.ch26
69
Marianna Maspero, Koji Hashimoto, Robert L. Fairchild, Andrea Schlegel. Reply: Acute rejection after transplantation of machine perfused livers—We have barely scratched the surface. Hepatology 2023; 78(4) doi: 10.1097/HEP.0000000000000483
70
Julie R. Ingelfinger, Konstantinos N. Lazaridis, Nicholas F. LaRusso. Primary Sclerosing Cholangitis. New England Journal of Medicine 2016; 375(12) doi: 10.1056/NEJMra1506330
71
John E. Eaton, Jayant A. Talwalkar, Konstantinos N. Lazaridis, Gregory J. Gores, Keith D. Lindor. Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management. Gastroenterology 2013; 145(3) doi: 10.1053/j.gastro.2013.06.052
72
Shishir Shetty, David H Adams, Stefan G Hubscher. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2012; 8(7) doi: 10.1586/eci.12.65
73
August Tronstad Juliebø, Trine Folseraas, Tom Hemming Karlsen, Kirsten Muri Boberg, Kristine Wiencke, Xavier Verhelst, Fredrik Åberg, Palak Trivedi, Takashi ITO, Uta Merle, Richard Taubert, Jeremy Nayagam, Deepak Joshi, Antonio Molinaro, Marcial Sebode, Jessica Dyson, Mark Sonderup, Sergio Rodríguez Tajes, Oren Shibolet, Evan Clemens, Daniel Ganger, Juan F. Gallegos-Orozco, Arjmand Mufti, Lance L. Stein, Dilip Moonka, Carl Jorns, Gabriela Berlakovich, Piotr Kaliciński, Neil Halliday, Miguel Ángel Gómez Bravo, Chiara Mazzarelli, Jef Verbeek, Caroline den Hoed, Annalisa Berzigotti, John E. Eaton, Andreas Kremer. Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation. Journal of Hepatology 2026; 84(5) doi: 10.1016/j.jhep.2026.02.009
74
Sally Condon, Cynthia Levy, Eric F. Martin. Recurrent and De Novo Liver Disease After Liver Transplantation. Clinics in Liver Disease 2025; 29(2) doi: 10.1016/j.cld.2024.12.008
75
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Seminars in Liver Disease 2021; 41(03) doi: 10.1055/s-0041-1730950
76
Courtney L. Tuegel, Lauren A. Beste, Anne M. Larson. Primary Care of the Solid Organ Transplant Recipient. 2025;  doi: 10.1007/978-3-031-98076-3_5
77
Ivo Graziadei. Lebertransplantation. Wiener klinische Wochenschrift Education 2013; 8(2) doi: 10.1007/s11812-013-0059-1
78
Michael Huw Chapman, Douglas Thorburn, Gideon M Hirschfield, George G J Webster, Simon M Rushbrook, Graeme Alexander, Jane Collier, Jessica K Dyson, David EJ Jones, Imran Patanwala, Collette Thain, Martine Walmsley, Stephen P Pereira. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut 2019; 68(8) doi: 10.1136/gutjnl-2018-317993
79
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi. Transplantation of the Liver. 2015;  doi: 10.1016/B978-1-4557-0268-8.00084-1
80
Tatiana Hildebrand, Nadine Pannicke, Alexander Dechene, Daniel N. Gotthardt, Gabriele Kirchner, Florian P. Reiter, Martina Sterneck, Kerstin Herzer, Henrike Lenzen, Christian Rupp, Hannelore Barg‐Hock, Philipp de Leuw, Andreas Teufel, Vincent Zimmer, Frank Lammert, Christoph Sarrazin, Ulrich Spengler, Christian Rust, Michael P. Manns, Christian P. Strassburg, Christoph Schramm, Tobias J. Weismüller. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis. Liver Transplantation 2016; 22(1) doi: 10.1002/lt.24350
81
Tanja Schoknecht, Dorothee Schwinge, Stephanie Stein, Christina Weiler-Normann, Marcial Sebode, Sören Mucha, Benjamin Otto, Eva Ellinghaus, Felix Stahl, Andre Franke, Ansgar W Lohse, Johannes Herkel, Christoph Schramm. CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood. Journal of Leukocyte Biology 2017; 101(2) doi: 10.1189/jlb.5A1015-469R
82
Marina Berenguer, Marta Tejedor. Liver Transplantation. 2025;  doi: 10.1007/978-3-032-07072-2_28
83
Ellina Lytvyak, Dennis Wang, Devika Shreekumar, Maryam Ebadi, Yousef Alrifae, Andrew Mason, Aldo J. Montano-Loza. PSC-specific prognostic scores associated with graft loss and overall mortality in recurrent PSC after liver transplantation. Digestive and Liver Disease 2025; 57(6) doi: 10.1016/j.dld.2025.02.001
84
Isabelle Castro Vitor, Milena Ramos Tomé, Wellgner Fernandes Oliveira Amador, Igor Boechat Silveira, Marina de Assis Bezerra Cavalcanti Leite, Pedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, Yohanna Idsabella Rossi, Guilherme Grossi Lopes Cançado, Rodrigo Vieira Motta. Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta‐Analysis. Liver International 2026; 46(6) doi: 10.1111/liv.70673
85
Nobuhisa Akamatsu, Kiyoshi Hasegawa, Hiroto Egawa, Hideki Ohdan, Atsushi Yoshizawa, Norihiro Kokudo, Susumu Tazuma, Atsushi Tanaka, Hajime Takikawa. Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation – a multicenter retrospective study. Transplant International 2021; 34(5) doi: 10.1111/tri.13852
86
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitis. Pathology International 2016; 66(7) doi: 10.1111/pin.12427
87
Jie Zhou. CDC42: unlocking a novel therapeutic target for primary sclerosing cholangitis through Mendelian randomization. American Journal of Translational Research 2025; 17(2) doi: 10.62347/BTYN8678
88
Fei Hou, Hao-Feng Xiong, Ying Liu, Shuang Zhao, Yi-Zhi Zhang, Qian Kang, Jing-Yi Liu, Lin Wei, Wei Qu, Zhi-Gui Zeng, Zhi-Jun Zhu, Li-Ying Sun. Clinical outcomes of liver transplantation in Caroli syndrome: a retrospective analysis. Orphanet Journal of Rare Diseases 2025; 20(1) doi: 10.1186/s13023-025-03943-6
89
Taranika Sarkar Das, Raj Vuppalanchi. Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus. Clinics in Liver Disease 2025; 29(4) doi: 10.1016/j.cld.2025.06.010
90
Christopher L. Bowlus. The Rose and Mackay Textbook of Autoimmune Diseases. 2024;  doi: 10.1016/B978-0-443-23947-2.00020-5
91
Wenzel Schöning, Maximilian Schmeding, Florian Ulmer, Anne Andert, Ulf Neumann. Liver Transplantation for Patients with Cholestatic Liver Diseases. Visceral Medicine 2015; 31(3) doi: 10.1159/000431017
92
Ming-Li Yin, Hong-Li Song, Yang Yang, Wei-Ping Zheng, Tao Liu, Zhong-Yang Shen. Effect of <i>CXCR3/HO-1</i> genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection. World Journal of Gastroenterology 2017; 23(22): 4016-4038 doi: 10.3748/wjg.v23.i22.4016
93
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBD. Current Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
94
Debashree Debasish Das, Nikita Sharma, Pooja A Chawla. Current trends and future perspectives in the treatment of PBC and PSC: A review. Health Sciences Review 2022; 5 doi: 10.1016/j.hsr.2022.100065
95
Wajeeh Salah, M. Edwyn Harrison. Practical Gastroenterology and Hepatology Board Review Toolkit. 2016;  doi: 10.1002/9781119127437.ch86
96
N Simonian, M Brahmania, M Bhat, A Kim, HLA Janssen, BE Hansen, K Patel. Predictors of early and long-term readmissions and their association with survival after liver transplantation. Journal of Liver Transplantation 2024; 13 doi: 10.1016/j.liver.2023.100195
97
Tanja Elger, Muriel Huss, Johanna Loibl, Patricia Mester, Andreas Albert, Arne Kandulski, Martina Müller, Hauke Christian Tews, Christa Buechler. Elevated Serum Adiponectin Levels in Primary Sclerosing Cholangitis (PSC) Compared to Inflammatory Bowel Disease (IBD): A Potential Biomarker for PSC-IBD Screening. Livers 2026; 6(2) doi: 10.3390/livers6020015
98
Kate D. Williamson, Roger W. Chapman. Primary Sclerosing Cholangitis. Digestive Diseases 2014; 32(4) doi: 10.1159/000358150
99
Manuel Rodríguez-Perálvarez, Giacomo Germani, Vasilios Papastergiou, Emmanuel Tsochatzis, Evangelos Thalassinos, Tu Vinh Luong, Nancy Rolando, Amar Paul Dhillon, David Patch, James O’Beirne, Douglas Thorburn, Andrew Kenneth Burroughs. Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome. Journal of Hepatology 2013; 58(2) doi: 10.1016/j.jhep.2012.09.019
100
Ahmad Anouti, Madhukar S. Patel, Lisa B. VanWagner, William M. Lee, John J. Fung, George Cholankeril, Christine S. Hwang, Arjmand R. Mufti, Shannan Tujios, Thomas Kerr, Nicole E. Rich, Jeremy Louissaint, Dev M. Desai, Parsia A. Vagefi, Steven Hanish, Jigesh Shah, Amit G. Singal, Thomas G. Cotter. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver International 2023; 43(10) doi: 10.1111/liv.15689
101
Elisa Catanzaro, Enrico Gringeri, Nora Cazzagon, Annarosa Floreani, Umberto Cillo, Patrizia Burra, Martina Gambato. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. Journal of Personalized Medicine 2024; 14(3) doi: 10.3390/jpm14030222
102
R.W. Chapman, K.D. Williamson. The Digestive Involvement in Systemic Autoimmune Diseases. Handbook of Systemic Autoimmune Diseases 2017; 13 doi: 10.1016/B978-0-444-63707-9.00007-6
103
Claire Kelly, Yoh Zen, Michael A. Heneghan. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(2) doi: 10.1016/j.jceh.2022.07.002
104
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 2015; 50(6) doi: 10.3109/00365521.2015.1028996
105
Mette Vesterhus, Tom Hemming Karlsen. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities. Journal of Gastroenterology 2020; 55(6) doi: 10.1007/s00535-020-01681-z
106
Konstantinos N. Lazaridis, Nicholas F. LaRusso. The Cholangiopathies. Mayo Clinic Proceedings 2015; 90(6) doi: 10.1016/j.mayocp.2015.03.017
107
Marcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel-Anselmino, Reinhild Klein, Andreas E. Kremer, Petra L. Jansen, Michael Melter, Peter Schirmacher, Christoph Schramm, Martina Sterneck, Christian P. Strassburg, Christina Weiler-Normann, Ansgar W. Lohse. Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline. Zeitschrift für Gastroenterologie 2026; 64(05) doi: 10.1055/a-2769-2475
108
Neelam G Gidwaney, Swati Pawa, Kiron M Das. Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World Journal of Gastroenterology 2017; 23(14): 2459-2469 doi: 10.3748/wjg.v23.i14.2459
109
Holmfridur Helgadottir, Trine Folseraas, Gunter Kemmerich, Lars Aabakken, Kristin Kaasen Jørgensen, Mette Vesterhus. Primær skleroserende kolangitt. Tidsskrift for Den norske legeforening 2023; 143(17) doi: 10.4045/tidsskr.23.0156
110
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 2017; 67(6) doi: 10.1016/j.jhep.2017.07.022
111
Lauren A. Beste, Anne M. Larson. Primary Care of the Solid Organ Transplant Recipient. 2020;  doi: 10.1007/978-3-030-50629-2_5
112
Jessica K Dyson, Ulrich Beuers, David E J Jones, Ansgar W Lohse, Mark Hudson. Primary sclerosing cholangitis. The Lancet 2018; 391(10139) doi: 10.1016/S0140-6736(18)30300-3
113
Andrew L. Mason, Aldo J. Montano-Loza. Systematic Investigation of Elevated Cholestatic Enzymes During The Third Posttransplant Month. Liver Transplantation 2013; 19(Suppl. 2) doi: 10.1002/lt.23742
114
Andrzej Chruscinski, Stephen Juvet, Sajad Moshkelgosha, Eberhard Renner, Leslie Lilly, Nazia Selzner, Christopher Bredeson, David Grant, Oyedele Adeyi, Sandra Fischer, Anthony J. Demetris, Jianhua Zhang, Maor Epstein, Meaghan Macarthur, Anne Marie Clement, Korosh Khalili, David Allan, Sultan Altouri, Isabelle Bence-Bruckler, Mark Cattral, Jill Fulcher, Zita Galvin, Anand Ghanekar, Paul Greig, Lothar Huebsch, Atul Humar, Andrea Kew, Natasha Kekre, Tae Kyoung Kim, Sheryl McDiarmid, Lisa Martin, Ian McGilvray, Mitchell Sabloff, Gonzalo Sapisochin, Markus Selzner, Robert Smith, Kathryn Tinckam, Tae Joon Yi, Gary Levy, Harold Atkins. Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study. Transplantation 2022; 106(3) doi: 10.1097/TP.0000000000003829
115
Murat Harputluoglu, Mehmet Zeki Calgin, Engin Ataman, Deniz Tikici, Koray Kutluturk, Ramazan Kutlu, Cumali Savas Efe, Sezai Yilmaz. Outcomes of patients with primary sclerosing cholangitis after liver transplantation in a predominantly living donor liver transplant center. Journal of Liver Transplantation 2023; 12 doi: 10.1016/j.liver.2023.100186
116
Ali Reza Safarpour, Hassan Askari, Farshid Ejtehadi, Asaad Azarnezhad, Ehsan Raeis-Abdollahi, Amir Tajbakhsh, Mohammad Foad Abazari, Firoozeh Tarkesh, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Kamran Bagheri Lankarani, Fardad Ejtehadi. Cholangiocarcinoma and liver transplantation: What we know so far?. World Journal of Gastrointestinal Pathophysiology 2021; 12(5): 84-105 doi: 10.4291/wjgp.v12.i5.84
117
Ahmed Nahian, Lisa McFadden, Tanzina Ela. State-Level Geographic Disparities in Liver Transplant Access: Waitlist Outcome Patterns. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114212
118
Lukas Bajer, Antonij Slavcev, Peter Macinga, Eva Sticova, Jan Brezina, Matej Roder, Radim Janousek, Pavel Trunecka, Julius Spicak, Pavel Drastich. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with <i>de novo</i> inflammatory bowel disease. World Journal of Gastroenterology 2018; 24(43): 4939-4949 doi: 10.3748/wjg.v24.i43.4939
119
Adam VanHuis, Veronica Loy. Myth: Liver Transplant Provides a Cure for Liver Disease. Clinical Liver Disease 2019; 13(6) doi: 10.1002/cld.770
120
René P. Michel, Victoria A. Marcus. Pathology of Transplantation. 2016;  doi: 10.1007/978-3-319-29683-8_6
121
S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Zeitschrift für Gastroenterologie 2025; 63(06) doi: 10.1055/a-2558-5204
122
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System. 2018;  doi: 10.1002/9781119237662.ch18
123
Yan-Hua Lai, Wei-Dong Duan, Qiang Yu, Sheng Ye, Nian-Jun Xiao, Dong-Xin Zhang, Zhi-Qiang Huang, Zhan-Yu Yang, Jia-Hong Dong. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease. World Journal of Gastroenterology 2015; 21(20): 6296-6303 doi: 10.3748/wjg.v21.i20.6296
124
Melinda J. Yeh, So Yeon Kim, Kartik S. Jhaveri, Spencer C. Behr, Nieun Seo, Benjamin M. Yeh. Imaging of autoimmune biliary disease. Abdominal Radiology 2017; 42(1) doi: 10.1007/s00261-016-0903-8
125
Dorothee Schwinge, Christoph Schramm. Sex-related factors in autoimmune liver diseases. Seminars in Immunopathology 2019; 41(2) doi: 10.1007/s00281-018-0715-8
126
Keith D Lindor, Kris V Kowdley, Edwyn M Harrison. ACG Clinical Guideline: Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2015; 110(5) doi: 10.1038/ajg.2015.112
127
Rianne van Rijn, Chikako Endo, Efrayim H. Küçükerbil, Hans Blokzijl, Joris Blondeel, Miriam Cortes Cerisuelo, Minneke J. Coenraad, Sarwa Darwish Murad, Michail Doukas, Hasan Eker, Robbert J. de Haas, Volkert A.L. Huurman, Vincent E. de Meijer, Diethard Monbaliu, Ivo J. Schurink, Jules J.G. Slangen, Wojciech G. Polak, Jeroen de Jonge, Robert J. Porte. Long-term Follow-up After Hypothermic Oxygenated Machine Perfusion in DCD Liver Transplantation. Annals of Surgery 2025; 282(5) doi: 10.1097/SLA.0000000000006876
128
Helen S. Te, Vatche G. Agopian, Anthony J. Demetris, Paul Y. Kwo, Brendan M. McGuire, Mark W. Russo, Nazia Selzner, W. Kenneth Washburn, Gerald Scott Winder, Thomas D. Schiano. AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and management of graft-related complications. Liver Transplantation 2026; 32(3) doi: 10.1097/LVT.0000000000000715
129
Non-Neoplastic Diseases of the Liver. 2022;  doi: 10.55418/9781933477183-11
130
Tom H. Karlsen, Kirsten Muri Boberg. Update on primary sclerosing cholangitis. Journal of Hepatology 2013; 59(3) doi: 10.1016/j.jhep.2013.03.015
131
Monica Tincopa. CAQ Corner: Long‐term medical complications of liver transplantation. Liver Transplantation 2023; 29(5) doi: 10.1002/lt.26486
132
Cynthia Levy, Stephen Caldwell, Parvez Mantry, Velimir Luketic, Charles S. Landis, Jonathan Huang, Edward Mena, Rahul Maheshwari, Kevin Rank, Jun Xu, Vladislav A. Malkov, Andrew N. Billin, Xiangyu Liu, Xiaomin Lu, William T. Barchuk, Timothy R. Watkins, Chuhan Chung, Robert P. Myers, Kris V. Kowdley. Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study. Clinical and Translational Gastroenterology 2024; 15(8) doi: 10.14309/ctg.0000000000000744
133
Gary C. Kanel. Atlas of Liver Pathology. 2024;  doi: 10.1016/B978-0-323-82533-7.00013-2
134
David Choi, Mengyuan Liu, Dharani Guttikonda, Kelly Galen, Grace Guzman, Hoonbae Jeon, Costica Aloman. Recipient risk factors for acute cellular rejection after orthotopic liver transplant ‐ a single‐center, retrospective study. Transplant International 2020; 33(12) doi: 10.1111/tri.13756
135
Nabiha Faisal, Eberhard L Renner. Recurrence of autoimmune liver diseases after liver transplantation. World Journal of Hepatology 2015; 7(29): 2896-2905 doi: 10.4254/wjh.v7.i29.2896
136
Michael E. Sutton, Rico D. Bense, Ton Lisman, Eric J. van der Jagt, Aad P. van den Berg, Robert J. Porte. Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy. Liver Transplantation 2014; 20(4) doi: 10.1002/lt.23827
137
Xiaoying Liu, Sarah A. Taylor, Stela Celaj, Josh Levitsky, Richard M. Green. Expression of unfolded protein response genes in post-transplantation liver biopsies. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02459-8
138
Christopher L. Bowlus. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_25
139
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3) doi: 10.1016/j.jhep.2022.05.011
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.